• No results found

[PDF] Top 20 Expression of CD44 and CD133 in Glioma Stem Cells

Has 10000 "Expression of CD44 and CD133 in Glioma Stem Cells" found on our website. Below are the top 20 most common "Expression of CD44 and CD133 in Glioma Stem Cells".

Expression of CD44 and CD133 in Glioma Stem Cells

Expression of CD44 and CD133 in Glioma Stem Cells

... grade glioma remains poor ...tumor stem cells, along with the expression of some characteristics of neural stem cells ...cancerous stem cells [4, 5]. Cancer ... See full document

7

Prognostic value of the expression of cancer stem cell-related markers CD133 and CD44 in hepatocellular carcinoma: From patients to patient-derived tumor xenograft models

Prognostic value of the expression of cancer stem cell-related markers CD133 and CD44 in hepatocellular carcinoma: From patients to patient-derived tumor xenograft models

... the expression of CD133/ ...the expression of CD133/CD44 using two hepatitis B surface antigens, HBsAg and HBeAg, as indicators in the present study, indicating the non-viral origin of ... See full document

13

THE EXPRESSION PROFILING OF ALDH3A1, CD44, CD133 AND TNFRSF9 IN HUMAN BREAST CANCER STEM CELLS

THE EXPRESSION PROFILING OF ALDH3A1, CD44, CD133 AND TNFRSF9 IN HUMAN BREAST CANCER STEM CELLS

... as; cells with high ALDH had a large formation of spheres whilst when they had low ALDH there was no formation of ...cancer stem cells. Similar results were obtained for CD133 as a marker in ... See full document

27

Osteopontin alters DNA methylation through up-regulating DNMT1 and sensitizes CD133+/CD44+ cancer stem cells to 5 azacytidine in hepatocellular carcinoma

Osteopontin alters DNA methylation through up-regulating DNMT1 and sensitizes CD133+/CD44+ cancer stem cells to 5 azacytidine in hepatocellular carcinoma

... of CD133+/CD44+ ...that CD133+/CD44+ cells with high OPN expression up-regulated DNMT1, which made CD133+/CD44+ cells more sensitive to DNMT1 inhibitor, ... See full document

14

Therapeutics targeting CD90-integrin-AMPK-CD133 signal axis in liver cancer

Therapeutics targeting CD90-integrin-AMPK-CD133 signal axis in liver cancer

... cancer stem cells have been identified by several markers [44, 45], including EpCAM, CD90, CD133, CD44, CD24, and ...CD13. CD133 is co-expressed with many other markers that are used to ... See full document

15

An Artificial Niche for Circulating Endothelial Cells During Tumor Angiogenesis Mediated by Prostate Cancer Stem Cells

An Artificial Niche for Circulating Endothelial Cells During Tumor Angiogenesis Mediated by Prostate Cancer Stem Cells

... the cells. The CD133+ cells were selected using immuno-magnetic beads and analysed for the presence of ...of CD133+ in the sorted samples was always higher than 94%. The CD133+ ... See full document

5

Coexpression analysis of CD133 and CD44 identifies Proneural and Mesenchymal subtypes of glioblastoma multiforme

Coexpression analysis of CD133 and CD44 identifies Proneural and Mesenchymal subtypes of glioblastoma multiforme

... the stem cell markers CD133 and CD44 indicate molecular subtype in Glioblastoma Multiforme ...Glioblastoma Stem-Progenitor Cell (GSPC) ...with stem cell markers, which were then used to ... See full document

14

Original Article Expression of cancer stem cell markers and their correlation with pathogenesis in vascular tumors

Original Article Expression of cancer stem cell markers and their correlation with pathogenesis in vascular tumors

... tumorigenic cells sub- set commonly called cancer stem cells ...cer stem cells hypothesis holds that cancer stem cells may contribute to the initia- tion, progression and ... See full document

13

Enrichment of Prostate Cancer Stem-Like Cells from Human Prostate Cancer Cell Lines by Culture in Serum-Free Medium and Chemoradiotherapy

Enrichment of Prostate Cancer Stem-Like Cells from Human Prostate Cancer Cell Lines by Culture in Serum-Free Medium and Chemoradiotherapy

... cancer stem cells (CSCs) hypothesis postu- lates that a small subpopulation of cancer cells drive tumor growth and metastasis, and that CSCs are more resistant to toxic injuries and chemoradiation ... See full document

8

Cancer Stem Cell Markers CD44, CD133 in Primary Gastric Adenocarcinoma

Cancer Stem Cell Markers CD44, CD133 in Primary Gastric Adenocarcinoma

... for CD44 (Abcam,DF1485, 1.200) and CD133 (Abcam, ...the expression of these markers and clinicopathologic features including age, sex, tumor size, histologic type of gastric adenocarcinoma, depth of ... See full document

8

CD133 CD54 CD44 circulating tumor cells as a biomarker of treatment selection and liver metastasis in patients with colorectal cancer

CD133 CD54 CD44 circulating tumor cells as a biomarker of treatment selection and liver metastasis in patients with colorectal cancer

... high expression. CD133 has been accepted as a cancer stem cell marker for colon cancer [28-30] and the expression of CD133 in the CRC primary tissue or liver metastases has been ... See full document

15

Matrigel modulates a stem cell phenotype and promotes tumor formation in a mantle cell lymphoma cell line

Matrigel modulates a stem cell phenotype and promotes tumor formation in a mantle cell lymphoma cell line

... either CD133/ CD44 co-expression or the SP functional ...the stem cell niche is comprised of numerous cel- lular and non-cellular entities, the ECM is of particular interest as it is known to ... See full document

13

Brca1 breast tumors contain distinct CD44+/CD24  and CD133+cells with cancer stem cell characteristics

Brca1 breast tumors contain distinct CD44+/CD24 and CD133+cells with cancer stem cell characteristics

... their expression with normal mammary gland from C57/Bl6 ...to expression of Pmca4, a housekeeping gene ...Abcg2. Expression of Abcg2 was higher in all cell lines except for ...B.15 cells, as ... See full document

16

ASSOCIATION OF TUMOR ANGIOGENIC CELLS (CD133+/ VEGFA+) AND CIRCULATING CANCER STEM CELLS (CD133+/VEGFR2-) IN ASTROCYTIC GLIOMA PATIENTS

ASSOCIATION OF TUMOR ANGIOGENIC CELLS (CD133+/ VEGFA+) AND CIRCULATING CANCER STEM CELLS (CD133+/VEGFR2-) IN ASTROCYTIC GLIOMA PATIENTS

... the glioma stem cells secrete VEGF due to the hypoxia condition and this VEGF level is much more elevated compared to non- stem cancer ...The glioma stem cells upregulate ... See full document

8

Frequent Gene Products and Molecular Pathways Altered in Prostate Cancer- and Metastasis-Initiating Cells and Their Progenies and Novel Promising Multitargeted Therapies

Frequent Gene Products and Molecular Pathways Altered in Prostate Cancer- and Metastasis-Initiating Cells and Their Progenies and Novel Promising Multitargeted Therapies

... the CD133 + /CD44 + cell fraction and the bulk PC cell mass detected by cytometric analyses ...enhanced expression of the MIC-1 level was observed during PC pro- gression to CRPCs and after ... See full document

16

Review Article Clinicopathological and prognostic significance of cd133 in esophageal cancer: a meta-analysis

Review Article Clinicopathological and prognostic significance of cd133 in esophageal cancer: a meta-analysis

... as CD44, CD24, CD166 and EpCAM have been verified as putative CSC markers in ...that CD133 is the best sole marker to predict low patient survival, while the combined analysis of CD133, CD44, ... See full document

10

Expression of intestinal stem cell and cancer stem cell markers in submucosal invasion and its prognostic significance in gastric cancers

Expression of intestinal stem cell and cancer stem cell markers in submucosal invasion and its prognostic significance in gastric cancers

... cancer stem cell (CSC) model suggests that tumor growth is induced by a small group of self- sustaining cells with longevity, infinite proliferation, and the ability to differentiate into a heterogeneous ... See full document

32

Prognostic value of CD44 expression in patients with hepatocellular carcinoma: meta-analysis

Prognostic value of CD44 expression in patients with hepatocellular carcinoma: meta-analysis

... of cells called cancer stem-like cells (CSC), which exhibit self-renewing capacities and are responsi- ble for tumor maintenance and metastasis [3] and pos- sibly for resistance towards chemotherapy ... See full document

9

A rational approach for cancer stem-like cell isolation and characterization using CD44 and prominin-1(CD133) as selection markers

A rational approach for cancer stem-like cell isolation and characterization using CD44 and prominin-1(CD133) as selection markers

... that CD133 is expressed in primary tumors and that CD133-positive cells had high proliferative potential and exhibited clonogenic expansion ...[32]. CD44 is expressed in breast, prostate, ... See full document

17

CD133 expression is not restricted to stem cells, and both CD133+ and CD133– metastatic colon cancer cells initiate tumors

CD133 expression is not restricted to stem cells, and both CD133+ and CD133– metastatic colon cancer cells initiate tumors

... cancer stem cells are believed to originate from a rare population of putative CD133 + intestinal stem ...cancer cells expresses CD133, and that only these CD133 + cancer ... See full document

11

Show all 10000 documents...